Reuters: A panel of outside experts to the FDA, including David Blumenthal, assistant professor of medicine, unanimously voted against an experimental drug to prevent gout flares, based on trials that tested the drug for only 16 weeks. “A lot of the patients where we envision using this drug are going to take it for longer than 16 weeks. It’s hard for me to allow patients to be exposed (without longer safety data),” he said.
Medicine’s David Blumenthal sits on FDA expert panel reviewing gout drug
- Dittrick Medical History Center and Museum creates coloring pages of collection
- School of Law to offer new executive master’s degree program
- Law’s Jonathan Adler weighs in on Supreme Court stay of Clean Power Act
- Doctoral candidate Joshua Grubbs discusses study on narcissism in Millennials
- Sign up now for University Farm’s Community Supported Agriculture Program